Navigation Links
Therapeutic prospects beyond Vioxx

Researchers at the University of Pennsylvania School of Medicine have clarified the mechanism by which drugs like Celebrex and Vioxx cause heart problems, in multiple animal models. The findings offer the prospect of a new generation of anti-inflammatory drugs that bypass this issue, as reported in the April 13 advanced online edition and May print issue of The Journal of Clinical Investigation.

"Although these results are in mice, not people, they raise an exciting possibility which can be tested in humans," says senior author Garret FitzGerald, MD, Director of Penn's Institute for Translational Medicine and Therapeutics,

Ever since the association of selective inhibitors of COX-2 ?Vioxx, Bextra, and Celebrex ?with an increased incidence of heart attack and stroke, there has been intense interest in understanding the mechanism involved. Clarification of this issue offers the prospect of conserving the clinical benefit of these drugs for patients with arthritis, while managing the risk.

Almost 10 years ago, FitzGerald noticed that both Celebrex and Vioxx depressed in healthy individuals a protective fat called prostacyclin, while leaving unaltered a harmful one called thromboxane. This led him to predict that drugs in this class might confer a cardiovascular risk before either reached the US market.

In the present studies, the investigators used multiple genetically manipulated mice ?including mice that mimicked the impact of either COX-2 inhibitors or low-dose aspirin and compared them with treating healthy mice with COX-2 inhibitors, such as Celebrex. They found that genetic disruption of COX-2; inhibition of the enzyme by different inhibitors; and disruption of prostacyclin's effects by removing its receptor all had the same effect ?a predisposition to clotting and an elevation of blood pressure. "This provides compelling evidence in support of the original hypothesis," says co-author Colin Funk, PhD, who has collaborated with Fit
'"/>

Source:University of Pennsylvania School of Medicine


Page: 1 2 3

Related biology news :

1. New Therapeutic Target Identified In Inherited Brain Tumor Disorder
2. Therapeutic role found for carbon monoxide
3. Protease inhibitors reach beyond HIV
4. NC State researchers redesign life for Mars and beyond
5. New classification of eukaryotes has implications for AIDS treatment, agriculture and beyond
6. Avian influenza virus in mammals spreads beyond the site of infection to other organ systems
7. Rotavirus can spread beyond the intestine
8. Parasites impact goes beyond host to affect ecosystem
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Therapeutic prospects beyond Vioxx

(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
(Date:3/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces its biometric payment technology, ... featured in 2015 "I Want That" International CES Special, ... the DIY Network.   DIY,s "I Want ... site of the 2015 International CES for a firsthand ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... , From neurosurgery to bar code readers, lasers have been ... introduced in the late 1950,s. Now, with the work being ... developed a way to use lasers to study the splicing ... to sustain advanced organisms, including human life. This process of ...
... study led by a University of Florida researcher uses tracking ... some of the fish swim directly to targeted locations. ... orient at large distances, with tiger sharks swimming in direct ... areas about 30 miles away, said lead author Yannis Papastamatiou, ...
... been selected as one of seven recipients to share ... to promote preventive care and reduce health care disparities ... its Centering Pregnancy program to address perinatal health care ... bring pregnant women with similar backgrounds together for group ...
Cached Biology News:Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 3New UF study shows some sharks follow 'mental map' to navigate seas 2New UF study shows some sharks follow 'mental map' to navigate seas 3Boston Medical Center to receive $245,000 grant from Attorney General Martha Coakley 2
(Date:5/1/2015)... 1, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ... immune therapies for solid tumor cancers, announced today that ... tranche of a $40 million investment from Woodford investment ... invested $25 million in NW Bio on November 19, ... agreement with the Company for a further $40 million ...
(Date:5/1/2015)... Charlotte, N.C. (PRWEB) May 01, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced that Pinku ... Award, the UNC Board of Governors’ highest faculty ... contributions to humanity’s welfare , for her innovative research ... O. Max Gardner Award represents a crowning moment in ...
(Date:5/1/2015)... - BioAmber Inc. (NYSE: BIOA ), an industrial ... priced an underwritten registered offering of 3,900,000 shares of ... share, and granted the underwriters in the offering a ... shares of its common stock. The gross proceeds to ... to close on May 6, 2015, subject to customary ...
(Date:5/1/2015)... May 1, 2015 Pfenex Inc. (NYSE ... the development of biosimilar therapeutics including high value ... its first quarter 2015 financial results will be ... open of market. At 8:30 am Eastern Time, Pfenex ... the financial results and provide a business update. A ...
Breaking Biology Technology:NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3OncoTAb CSO Awarded the University of North Carolina’s O. Max Gardner Award 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2
... Va., Aug. 20 Evolvent Technologies, Inc. (Evolvent), a ... government, announced today that it was awarded a contract ... for enhancements to the Bidirectional Health Information Exchange (BHIE) ... DoD information on a shared patient population. , ...
... researchers have incorporated inorganic nanoparticles that join with ... structures that have unusual optical and mechanical properties. ... growth and assembly processes of natural materials, taking ... reduce metal ions to produce nanoparticles without harsh ...
... MOUNTAIN VIEW, Calif., Aug. 19 Los ... innovator of cavity-enhanced laser-based instrumentation for analyses of gases and liquids, ... p e Analyzer (LWIA). "Our new ... of oxygen and hydrogen in liquid water on the market today," ...
Cached Biology Technology:Evolvent Awarded Health Information Exchange Contract 2Bio-enabled, surface-mediated approach produces nanoparticle composites 2Bio-enabled, surface-mediated approach produces nanoparticle composites 3Los Gatos Research Introduces Second Generation Liquid-Water Isotope Analyzer 2
... Clone/PAD: ZMD.283. Immunogen: Fusion ... Specificity: Specific for ASIP/PAR-3 (atypical PKC ... This antigen is not related to ... Reactivity: Human Dog Xenopus (positive controls: ...
...
Request Info...
normal rat IgM AF647...
Biology Products: